Researchers have developed an AI algorithm capable of generating intricate 'sikku' kolam patterns, traditionally drawn by hand in South India. This innovative approach transforms a cultural art form into a complex computational challenge, with potential applications in various fields.
Researchers have developed an AI algorithm capable of generating intricate 'sikku' kolam patterns, an ancient Indian art form traditionally drawn by hand. The algorithm transforms this cultural practice into a complex computational challenge with potential applications in various technical fields.
For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.
Simplifying investment policies at the micro level and introducing a time-bound framework will be critical for India's growth targets, notes Krishna Ella.
Asia's richest man Mukesh Ambani on Thursday said his oil-to-telecom-and-retail conglomerate is not seeking short-term profit but is in the business of creating wealth for the nation. Speaking at the company's annual shareholder meeting, he said all businesses of Reliance Industries Ltd continue to be key drivers of the Indian economy and have become a success story. "We are not in the business of pursuing short-term profit and hoarding wealth. "We are in the business of creating wealth for India," he said.
The Tata Group is one of the very few Indian MNCs which has carved out a niche in China's highly competitive market, notes Rup Narayan Das.
The China threat continues to resonate in the strategic partnership between India and the USA, points out Rup Narayan Das.
The customs officials, based on an intelligence input, halted a Malta-flagged merchant ship -- CMA CGM Attila -- at the port en route to Karachi on January 23 and inspected the consignment, which included a Computer Numerical Control (CNC) machine, originally manufactured by an Italian company.
In the months immediately following the 2024 tragedy, reporting on the landslide per se had been a straightforward affair. On one side was death and destruction. On the other side, survivors and the business of survival. It was black and white. What direction to take was clear. Rehabilitation in comparison, felt like a complex situation. One that is fraught with shades of grey. As grey as human life, explains Shyam G Menon.
Think beyond engineering and medicine.
The Indian Space Research Organisation (ISRO) is set to welcome the new year with the launch of its first X-Ray Polarimeter Satellite that would offer insights into celestial objects like black holes, onboard a Polar Satellite Launch Vehicle rocket on Monday.
Once deployed and operational, it will be used to support the satellite imagery requirements of various agencies within the government of Singapore.
The academic centrepiece of this initiative will be an integrated dual degree MD-PhD programme aimed at creating a new breed of physician-scientists, who will pursue careers in clinical research to develop new treatments and healthcare solutions, driven by a bench-to-bedside philosophy, a statement said.
The primary satellite TeLEOS-2 is a synthetic aperture radar satellite developed under partnership between Defence Science and Technology Agency (DSTA) representing the Government of Singapore and ST Engineering.
The ISRO on Sunday scripted yet another history after its LVM3 rocket successfully placed 36 satellites of United Kingdom-based OneWeb group company into intended orbits.
Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.
India is likely to become a $40 trillion economy by 2047 -- a 13-fold jump from its current size -- driven primarily by a clean energy revolution and digitalisation, billionaire Mukesh Ambani said on Tuesday. Ambani's estimate for the Indian economy, currently the fifth largest in the world behind only the US, China, Japan and Germany, is more optimistic than Asia's richest man Gautam Adani, who last week stated that India will become a $30 trillion economy by 2050 on back of rising consumption and socio-economic reforms. "From a 3 trillion-dollar economy, India will grow to become a 40 trillion-dollar economy by 2047, ranking among the top three economies of the world," Ambani said at the 10th convocation of Pandit Deendayal Energy University in Gandhinagar.
More than 70 per cent of Indian youth aged between 15 and 29 can't!
Edtech major Byju's on Thursday introduced a new 'two-teacher' feature for its after-school online tutoring programme - Byju's Classes, a move aimed at delivering better learning experiences and outcomes. The two-teacher advantage offering - which will be available as a separate offering at about Rs 2,500 per month - will see students being taught by one expert teacher who uses strong visuals and storytelling to explain topics in-depth to ensure conceptual clarity. The second teacher will solve instant doubts, paying individual attention and making the sessions interactive and engaging.
If things go according to plan, the vaccine would be available in the market by the end of this year.
INS Vikrant is being delivered about six years late and at a cost of about Rs 20,000 crore instead of the sanctioned Rs 3,261 crore.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
'The virus of trust deficit seems to be taking a toll of the friendship built over the years by succeeding leaderships of the two countries,' notes Rup Narayan Das.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries.
Just over 22 minutes into the flight, the rocket put Astrosat into orbit at an altitude of 650 km above the earth
Consolidation is the prime mood of the Indian equity market at the moment.
India procured around 5 lakh rapid antibody test kits from the two Chinese firms, Guongzhou Wondfo Biotech and Livzon Diagnostics, and they were distributed to several states reporting rising cases of the coronavirus infection.
The winter session of Parliament will commence on November 26.
Odisha has claimed that Rasogolla originated from the Jagannath Temple in Puri
As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.
Region takes about a third of all Indian fruit shipment and quarter of vegetables sold abroad; consignments from other states could face ban, too, if virus not contained
Boeing's plan involves setting up an Indian factory and the aerospace ecosystem to build the Block II Super Hornet.
This is the joint statement issued by the ministry of external affairs on the visit of US President Barack Obama to India.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
'15, 17 years back we were not even in existence in the US. Today nearly 1/3 of prescriptions written comes from India.' 'India is showing that in a very competitive environment -- like the US and Europe -- our industry is doing very well.'
The industry employs about 10 million workforce.
Can we make high speed 4G Internet available at 10 cents per GB, and make all voice calls free of cost -- that too in a large and diverse country like India? Can we make high-quality but simple breast cancer screening available to every woman, that too at the extremely affordable cost of $1 per scan? Can we make a portable, high-tech ECG machine which can provide reports immediately and that too at the cost of 8 cents a test? Can we make an eye imaging device that is portable, non-invasive and costs 3 times less that conventional devices? Can we make a robust test for mosquito-borne dengue, which can detect the disease on day 1, and that too at the cost of $2 per test? Amazingly, says Dr R A Mashelkar, the eminent scientist, all this has been achieved in India, not only by using technological innovation but also non-technological innovation.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances